2024-03-16 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 15567545 2024-03-16 2025-03-31 15567545 bus:FullAccounts 2024-03-16 2025-03-31 15567545 bus:Micro-entities 2024-03-16 2025-03-31 15567545 bus:AuditExempt-NoAccountantsReport 2024-03-16 2025-03-31 15567545 bus:SmallCompaniesRegimeForAccounts 2024-03-16 2025-03-31 15567545 bus:PrivateLimitedCompanyLtd 2024-03-16 2025-03-31 15567545 2024-03-16 2025-03-31 15567545 2025-03-31 15567545 bus:RegisteredOffice 2024-03-16 2025-03-31 15567545 core:WithinOneYear 2025-03-31 15567545 core:AfterOneYear 2025-03-31 15567545 1 2024-03-16 2025-03-31 15567545 bus:Director1 2024-03-16 2025-03-31 15567545 bus:Director1 2025-03-31 15567545 2023-03-16 15567545 bus:LeadAgentIfApplicable 2024-03-16 2025-03-31 15567545 2024-03-15 15567545 bus:OrdinaryShareClass1 2024-03-16 2025-03-31 15567545 bus:OrdinaryShareClass1 2025-03-31 15567545 core:PlantMachinery 2024-03-16 2025-03-31 15567545 core:PlantMachinery 2025-03-31 15567545 core:PlantMachinery 2024-03-15 15567545 core:ComputerEquipment 2024-03-16 2025-03-31 15567545 core:ComputerEquipment 2025-03-31 15567545 core:ComputerEquipment 2024-03-15 15567545 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 15567545 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-15 15567545 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 15567545 core:CostValuation core:Non-currentFinancialInstruments 2024-03-15 15567545 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 15567545 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15567545 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15567545 core:Non-currentFinancialInstruments 2025-03-31 15567545 core:Non-currentFinancialInstruments 2024-03-15 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15567545
England and Wales
VELLIO HEALTH LIMITED
Unaudited Financial Statements
Period of accounts Start date: 16 March 2024 End date: 31 March 2025

Vellio Health Limited Contents Page For the Period 16 March 2024 to 31 March 2025
Company information | 1
Balance sheet | 2

Vellio Health Limited Company Information For the Period 16 March 2024 to 31 March 2025
Director | Daria Ovuka
Registered Number | 15567545
Registered Office | 167-169 Great Portland Street London W1W 5PF
Accountants | Ludlow Painter Limited Produce House 1a Wickham Court Road West Wickham Kent BR4 9LN
1

Vellio Health Limited Balance Sheet As at 31 March 2025
|  | 2025
--- | --- | ---
|  | £ | £
Fixed assets |  |  | 11,945
Current assets |  | 496 |
Creditors: amount falling due within one year |  | (20,105) |
Net current assets |  |  | (19,609)
Total assets less current liabilities |  |  | (7,664)
Net assets |  |  | (7,664)
Capital and reserves |  |  | (7,664)
NOTES TO THE ACCOUNTS General Information Vellio Health Limited is a private company, limited by shares, registered in England and Wales, registration number 15567545, registration address 167-169 Great Portland Street, London, W1W 5PF. The presentation currency is £ sterling.
1. | Average number of employees Average number of employees during the period was 1.
For the period ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 18 November 2025 and were signed by:
-------------------------------- Daria Ovuka Director
2